journal
https://read.qxmd.com/read/38553420/auto-cleaving-bond-for-better-drugs
#21
JOURNAL ARTICLE
Jiaqi Guo, Annabelle Chang, Bing Xu
While bond formation has historically been the mainstay of medicinal chemistry, the phenomenon of bond cleavage has received less focus. However, the success of numerous oral medications demonstrates the importance of controlled cleavage in prodrugs to achieve desired therapeutic outcomes. Nevertheless, effective strategies to control this cleavage remain limited. This concept article introduces a novel approach: employing peptides as conjugates to drugs to modulate the hydrolysis of these conjugates and enhance drug efficacy...
March 29, 2024: ChemMedChem
https://read.qxmd.com/read/38532643/finding-the-ajoene-sweet-spot-structure-activity-relations-that-govern-its-blood-stability-and-cancer-cytotoxicity
#22
JOURNAL ARTICLE
Daniel A Kusza, Gerhard A Venter, Mandla Mabunda, James Biwi, Suman K Samanta, Johan D Klinck, Shivendra V Singh, Roger Hunter, Catherine H Kaschula
Ajoene is an organosulfur compound found in crushed garlic, that exerts its anti-cancer activity by S-thiolating cysteine residues on proteins. Its development is hampered due to limited bioavailability. In this study, we synthesised analogues of ajoene to probe the significance of the ajoene vinyl disulfide/sulfoxide core with respect to cytotoxicity and blood stability. Polar side groups were also incorporated to improve aqueous solubility. It was found that derivatives containing a vinyl disulfide functional group (4-7, as in ajoene), were more cytotoxic compared to analogues in which the double bond was removed, although the latter showed superior blood stability...
March 26, 2024: ChemMedChem
https://read.qxmd.com/read/38529661/uracil-and-pyridine-containing-hdac-inhibitors-displayed-cytotoxicity-in-colorectal-and-glioblastoma-cancer-stem-cells
#23
JOURNAL ARTICLE
Francesco Fiorentino, Emanuele Fabbrizi, Alessia Raucci, Beatrice Noce, Rossella Fioravanti, Sergio Valente, Chantal Paolini, Ruggero De Maria, Christian Steinkühler, Paola Gallinari, Dante Rotili, Antonello Mai
Cancer stem cells (CSCs) are a niche of highly tumorigenic cells featuring self-renewal, activation of pluripotency genes, multidrug resistance, and ability to cause cancer relapse. Seven HDACi (1-7), showing either hydroxamate or 2'-aminoanilide function, were tested in colorectal cancer (CRC) and glioblastoma multiforme (GBM) CSCs to determine their effects on cell proliferation, H3 acetylation levels and in-cell HDAC activity. Two uracil-based hydroxamates, 5 and 6, which differ in substitution at C5 and C6 positions of the pyrimidine ring, exhibited the greatest cytotoxicity in GBM (5) and CRC (6) CSCs, followed by the pyridine-hydroxamate 2, with 2- to 6-fold higher potency than the positive control SAHA...
March 26, 2024: ChemMedChem
https://read.qxmd.com/read/38526011/c9-functionalized-doxycycline-analogs-as-drug-candidates-to-prevent-pathological-%C3%AE-synuclein%C3%A2-aggregation-and-neuroinflammation-in-parkinson-s-disease-degeneration
#24
JOURNAL ARTICLE
Laurent Ferrié, Bruno Figadère, Clémence Rose, Rodrigo Hernán Tomas-Grau, Rosana Chehín, Brenda Zabala, Patrick Pierre Michel, Rita Raisman-Vozari, Jean-Michel Brunel
Doxycycline, a semi-synthetic tetracycline, is a widely used antibiotic for treating mild-to-moderate infections, including skin problems. However, its anti-inflammatory and antioxidant properties, combined with its ability to interfere with α-synuclein aggregation, make it an attractive candidate for repositioning in Parkinson's disease. Nevertheless, the antibiotic activity of doxycycline restricts its potential use for long-term treatment of Parkinsonian patients. In the search for non-antibiotic tetracyclines that could operate against Parkinson's disease pathomechanisms, eighteen novel doxycycline derivatives were designed...
March 25, 2024: ChemMedChem
https://read.qxmd.com/read/38523074/structural-analysis-of-the-macrocyclic-inhibitor-bi-4020-binding-to-egfr-kinase
#25
JOURNAL ARTICLE
Tyler S Beyett, Jaimin K Rana, Ilse K Schaeffner, David E Heppner, Michael Eck
A novel macrocyclic inhibitor of mutant EGFR (BI-4020) has shown promise in pre-clinical studies of T790M and C797S drug-resistant non-small cell lung cancer. To better understand the molecular basis for BI-4020 selectivity and potency, we have carried out biochemical activity assays and structural analysis with X-ray crystallography. Biochemical potencies agree with previous studies indicating that BI-4020 is uniquely potent against drug-resistant L858R/T790M and L858R/T790M/C797S variants. Structures show that BI-4020 is likely rendered selective due to interactions with the kinase domain hinge region as well as T790M, akin to Osimertinib...
March 24, 2024: ChemMedChem
https://read.qxmd.com/read/38523069/developing-dynamic-structure-based-pharmacophore-and-ml-trained-qsar-models-for-the-discovery-of-novel-resistance-free-ret-tyrosine-kinase-inhibitors
#26
JOURNAL ARTICLE
Ehsan Sayyah, Lalehan Oktay, Hüseyin Tunç, Serdar Durdagi
Activation of RET tyrosine kinase plays a critical role in the pathogenesis of various cancers, including non-small cell lung cancer, papillary thyroid cancers, multiple endocrine neoplasia type 2A and 2B (MEN2A, MEN2B), and familial medullary thyroid cancer. Gene fusions and point mutations in the RET proto-oncogene result in constitutive activation of RET signaling pathways. Consequently, developing effective inhibitors to target RET is of utmost importance. Small molecules have shown promise as inhibitors by binding to the kinase domain of RET and blocking its enzymatic activity...
March 24, 2024: ChemMedChem
https://read.qxmd.com/read/38517377/development-of-benzimidazole-substituted-spirocyclopropyl-oxindole-derivatives-as-cytotoxic-agents-tubulin-polymerization-inhibition-and-apoptosis-inducing-studies
#27
JOURNAL ARTICLE
Akash P Sakla, Mohd Rabi Bazaz, Ashutosh Mahale, Pravesh Sharma, Durgesh Gurukkala Valapil, Onkar Prakash Kulkarni, Manoj P Dandekar, Nagula Shankaraiah
A series of spirocyclopropyl oxindoles with benzimidazole substitutions was synthesized and tested for their cytotoxicity against selected human cancer cells. Most of the molecules exhibited significant antiproliferative activity with compound 12p being the most potent. It exhibited significant cytotoxicity against MCF-7 breast cancer cells (IC50 value 3.14 ± 0.50 µM), evidenced by the decrease in viable cells and increased apoptotic features during phase contrast microscopy, AO/EB, DAPI and DCFDA staining studies...
March 22, 2024: ChemMedChem
https://read.qxmd.com/read/38516805/phosphine-catalyzed-synthesis-and-cytotoxic-evaluation-of-michael-adducts-of-the-sesquiterpene-lactone-arglabin
#28
JOURNAL ARTICLE
Alexey Valeryevich Salin, Andrey A Shabanov, Khasan R Khayarov, Daut R Islamov, Alexandra D Voloshina, Syumbelya K Amerhanova, Anna P Lyubina
A general method for chemo- and diastereoselective modification of anticancer natural product arglabin with nitrogen- and carbon-centered pronucleophiles under the influence of nucleophilic phosphine catalysts was developed. The locked s-cis-geometry of α-methylene-γ-butyrolactone moiety of arglabin favors for the additional stabilization of zwitterionic intermediate by electrostatic interaction between phosphonium and enolate oxygen centers, leading to the unprecedentedly efficient phosphine-catalyzed Michael additions to this sesquiterpene lactone...
March 22, 2024: ChemMedChem
https://read.qxmd.com/read/38503694/natural-distribution-structures-synthesis-and-bioactivity-of-hasubanan-alkaloids
#29
JOURNAL ARTICLE
Yingjie Wang, Fuxin Sun, Yapeng Liang, Di Zhou, Gang Chen, Ning Li
Hasubanan alkaloids represent a distinct class of alkaloids bearing a structural resemblance to morphine, predominantly found in herbals of the Stephania genus. Their intriguing molecular architecture and potential analgesic properties have captured the interest of medicinal chemists worldwide. This review meticulously examines the natural distribution, structural characteristics, biosynthetic pathways, synthetic methodologies, and biological activities of hasubanans.
March 19, 2024: ChemMedChem
https://read.qxmd.com/read/38489502/iodinated-4-4-bipyridines-with-antiproliferative-activity-against-melanoma-cell-lines
#30
JOURNAL ARTICLE
Paola Peluso, Victor Mamane, Ylenia Spissu, Giuseppina Casu, Alessandro Dessì, Roberto Dallocchio, Barbara Sechi, Giuseppe Palmieri, Carla Rozzo
In the last decade, biological processes involving halogen bond (HaB) as a leading interaction attracted great interest. However, although bound iodine atoms are considered powerful HaB donors, few iodinated new drugs were reported so far. Recently, iodinated 4,4'-bipyridines showed interesting properties as HaB donors in solution and in the solid state. In this paper, a study on the inhibition activity of seven halogenated 4,4'-bipyridines against malignant melanoma (MM) cell proliferation is described. Explorative dose/response proliferation assays were first performed with three 4,4'-bipyridines by using four MM cell lines and the normal BJ fibroblast cell line as control...
March 15, 2024: ChemMedChem
https://read.qxmd.com/read/38482564/discovery-of-potent-isoindolinone-inhibitors-that-target-an-active-conformation-of-parp1-using-dna-encoded-libraries
#31
JOURNAL ARTICLE
Kelly A McCarthy, Douglas J Marcotte, Sangram Parelkar, Crystal L McKinnon, Lindsay E Trammell, Eric L Stangeland, Rachael R Jetson
Inhibition of poly (ADP-ribose) polymerase-1 (PARP1), a DNA repair enzyme, has proven to be a successful strategy for the treatment of various cancers. With the appropriate selection conditions and protein design, DNA-encoded library (DEL) technology provides a powerful avenue to identify small molecules with the desired mechanism of action towards a target of interest. However, DNA-binding proteins, such as PARP1, can be challenging targets for DEL screening due to non-specific protein-DNA interactions. To overcome this, we designed and screened a PARP1 catalytic domain construct without the autoinhibitory helical domain...
March 14, 2024: ChemMedChem
https://read.qxmd.com/read/38477448/medical-applications-of-silver-and-gold-nanoparticles-and-core-shell-nanostructures-based-on-silver-or-gold-core-recent-progress-and-innovations
#32
JOURNAL ARTICLE
Kowalska Agata, Adamska Elzbieta, Beata Grobelna
Nanoparticles (NPs) of noble metals such as silver (Ag NPs) or gold (Au NPs) draw the attention of scientists looking for new compounds to use in medical applications. Scientists have used metal NPs because of their easy preparation, biocompatibility, ability to influence the shape and size or modification, and surface functionalization. However, to fully use their capabilities, both the benefits and their potential threats should be considered. One possibility to reduce the potential threat and thus prevent the extinction of their properties resulting from the agglomeration, they are covered with a neutral material, thus obtaining core-shell nanostructures that can be further modified and functionalized depending on the subsequent application...
March 13, 2024: ChemMedChem
https://read.qxmd.com/read/38459687/targeted-redox-balancing-through-pulmonary-nanomedicine-delivery-reverses-oxidative-stress-induced-lung-inflammation
#33
JOURNAL ARTICLE
Ria Ghosh, Monojit Das, Susmita Mondal, Amrita Banerjee, Lopamudra Roy, Anjan Kumar Das, Debasish Pal, Siddhartha Sankar Bhattacharya, Maitree Bhattacharyya, Samir Kumar Pal
Non-invasive delivery of drugs is important for the reversal of respiratory diseases essentially by-passing metabolic pathways and targeting large surface area of drug absorption. Here, we study the inhalation of a redox nano medicine namely citrate functionalized Mn3O4 (C-Mn3O4) duly encapsulated in droplet evaporated aerosols for the balancing of oxidative stress generated by the exposure of Chromium (VI) ion, a potential lung carcinogenic agent. Our optical spectroscopic in-vitro experiments demonstrates the efficacy of redox balancing of the encapsulated nanoparticles (NP) for the maintenance of a homeostatic condition...
March 8, 2024: ChemMedChem
https://read.qxmd.com/read/38456332/identification-of-potential-inhibitors-of-the-sars-cov-2-nsp13-helicase-via-structure-based-ligand-%C3%A2-design-molecular-docking-and-nonequilibrium-alchemical-simulations
#34
JOURNAL ARTICLE
Giorgio Di Paco, Marina Macchiagodena, Piero Procacci
We have assembled a computational pipeline   based on virtual screening, docking techniques, and nonequilibrium   molecular dynamics simulations,  with the goal of identifying possible   inhibitors of the SARS-CoV-2 NSP13 helicase, catalyzing by ATP   hydrolysis the unwinding of double or single-stranded RNA in the   viral replication process inside the host cell. The druggable sites   for broad-spectrum inhibitors are represented by the RNA binding sites at   the 5' entrance and 3' exit of the central channel, a structural motif   that is highly conserved across coronaviruses...
March 8, 2024: ChemMedChem
https://read.qxmd.com/read/38445815/spiro-acridine-compound-as-a-pteridine-reductase-1-inhibitor-in-silico-target-fishing-and-in-vitro-studies
#35
JOURNAL ARTICLE
Jéssika de Oliveira Viana, Marina Sena Mendes, Marcelo Santos Castilho, Ricardo Olímpio de Moura, Euzébio Guimarães Barbosa
Among the many neglected tropical diseases, Leishmaniasis ranks second in mortality rate and prevalence. In a previous study, acridine derivatives were synthesized and tested for their antileishmanial activity against L. chagasi. The most active compound identified in that study (1) showed a single digit EC50 value against the parasite (2.6 µM), but its macromolecular target remained unknown. Aiming to overcome this limitation, this work exploited inverse virtual screening to identify compound 1's putative molecular mechanism of action...
March 6, 2024: ChemMedChem
https://read.qxmd.com/read/38445366/combinatorial-libraries-of-bipodal-binders-of-the-insulin-receptor
#36
JOURNAL ARTICLE
Irena Selicharova, Benjamin Fabre, María Soledad Garre Hernández, Marta Lubos, Jan Picha, Zdenek Voburka, Katarína Mitrová, Jiri Jiracek
The binding process of insulin to its transmembrane receptor entails a sophisticated interplay between two proteins, each possessing two binding sites. Given the difficulties associated with the use of insulin in the treatment of diabetes, despite its remarkable efficacy, there is interest in smaller and more stable compounds than the native hormone that would effectively activate the receptor. Our study adopts a strategy focused on synthesizing extensive combinatorial libraries of bipodal compounds consisting of two distinct peptides linked to a molecular scaffold...
March 6, 2024: ChemMedChem
https://read.qxmd.com/read/38443744/copper-and-copper-complexes-in-tumor-therapy
#37
JOURNAL ARTICLE
Yingqiao Wang, Tingxi Tang, Yi Yuan, Nan Li, Xiaoqing Wang, Jian Guan
Copper (Cu), a crucial trace element in physiological processes, has garnered significant interest for its involvement in cancer progression and potential therapeutic applications. The regulation of cellular copper levels is essential for maintaining copper homeostasis, as imbalances can lead to toxicity and cell death. The development of drugs that target copper homeostasis has emerged as a promising strategy for anticancer treatment, with a particular focus on copper chelators, copper ionophores, and novel copper complexes...
March 5, 2024: ChemMedChem
https://read.qxmd.com/read/38426720/design-synthesis-and-biological-evaluation-of-eukaryotic-initiation-factor-2b-eif2b-activators
#38
JOURNAL ARTICLE
Yifeng Pei, Sentao Liu, Lixun Wang, Chao Chen, Mengqiu Hu, Yi Xue, Dezhong Guan, Lingfeng Xie, Hong Liao, Jinpei Zhou, Huibin Zhang
The eukaryotic initiation factor 2B (eIF2B) is a key regulator in protein-regulated signaling pathways and is closely related to the function of the central nervous system. Modulating eIF2B could retard the process of neurodegenerative diseases, including Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and vanishing white matter disease (VWM) et al. Here, we designed and synthesized a series of novel eIF2B activators containing oxadiazole fragments. The activating effects of compounds on eIF2B were investigated through testing the inhibition of ATF4 expression...
March 1, 2024: ChemMedChem
https://read.qxmd.com/read/38416542/chimeric-amphiphilic-disinfectants-quaternary-ammonium-quaternary-phosphonium-hybrid-structures
#39
JOURNAL ARTICLE
Moneya S Leatherbury, Laura Thierer, Christian A Sanchez, Germán Vargas-Cuebas, Ashley A Petersen, Lauren E Amoo, Elise L Bezold, Keshyne C Washington, M Brody Mistrot, Michael J Zdilla, William M Wuest, Kevin P C Minbiole
Cationic biocides play a crucial role in the disinfection of domestic and healthcare surfaces. Due to the rise of bacterial resistance towards common cationic disinfectants like quaternary ammonium compounds (QACs), the development of novel actives is necessary for effective infection prevention and control.  Toward this end, a series of 15 chimeric biscationic amphiphilic compounds, bearing both ammonium and phosphonium residues, were prepared to probe the structure and efficacy of mixed cationic ammonium-phosphonium structures...
February 28, 2024: ChemMedChem
https://read.qxmd.com/read/38408263/the-amphipathic-design-in-helical-antimicrobial-peptides
#40
REVIEW
Hai Bui Thi Phuong, Hoa Doan Ngan, Binh Le Huy, Hoang Vu Dinh, Huy Luong Xuan
Amphipathicity is a critical characteristic of helical antimicrobial peptides (AMPs). The hydrophilic region, primarily composed of cationic residues, plays a pivotal role in the initial binding to negatively charged components on bacterial membranes through electrostatic interactions. Subsequently, the hydrophobic region interacts with hydrophobic components, inducing membrane perturbation, ultimately leading to cell death, or inhibiting intracellular function. Due to the extensive diversity of natural and synthetic AMPs with regard to the design of amphipathicity, it is complicated to study the structure-activity relationships...
February 26, 2024: ChemMedChem
journal
journal
41191
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.